Skip to content

MTS MTS081001

by Micro Typing Systems, Inc

MTS MTS081001 is a medical device (FDA Class II; FDA product code KSF, Kit, Quality Control for Blood Banking Reagents) made by Micro Typing Systems, Inc, listed in FDA GUDID since 24 Aug 2016 (UDI-DI 10758750005949), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10758750005949 UDI-DI Date24 Aug 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
MTS Monoclonal Control Card
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Mts
Generic name
Antisera matrix (non-reactive) IVD, control
Model / Ref / Catalog
MTS081001
Primary DI / UDI-DI
10758750005949
FDA product code
KSF
GMDN term
Antisera matrix (non-reactive) IVD, control
Device class
Class II
Regulation number
864.9650
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code KSF (KIT, QUALITY CONTROL FOR BLOOD BANKING REAGENTS).

Other devices from Micro Typing Systems, Inc

See all devices from Micro Typing Systems, Inc →

Properties

  • Prescription use
  • Combination product
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)